中医药调控线粒体畸变治疗射血分数保留型心力衰竭的研究进展  

Research progress in traditional Chinese medicine regulating mitochondrial aberration for the treatment of HFpEF

在线阅读下载全文

作  者:马耀磊 李霄 李田甜[1,2] 黄湘龙 张晗 雷伟[1,2] MA Yaolei;LI Xiao;LI Tiantian;HUANG Xianglong;ZHANG Han;LEI Wei(Institute of Traditional Chinese Medicine,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China;State Key Laboratory of Component-based Chinese Medicine,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China)

机构地区:[1]天津中医药大学中医药研究院,天津301617 [2]天津中医药大学组分中药国家重点实验室,天津301617

出  处:《天津中医药》2024年第11期1475-1481,共7页Tianjin Journal of Traditional Chinese Medicine

基  金:国家自然科学基金项目(82104434)。

摘  要:心力衰竭(HF)是目前全球发病率和病死率最高的疾病之一。其中射血分数保留型心力衰竭(HFpEF)在HF中占比较高。目前的临床治疗手段仍然只是改善临床症状,不能有效地针对疾病本身进行治疗并降低HF造成的病死率。HFpEF的突出特征为舒张功能障碍和心室肌重构,而心室肌重构又与线粒体的畸变密切相关。文章将综述在HFpEF中导致线粒体生物发生障碍、线粒体裂变/融合动力学障碍和线粒体自噬异常等线粒体畸变过程的关键靶标蛋白,以及具有“益气温阳”作用的中药对HFpEF的作用机制及临床研究。总结分析可用于治疗HFpEF的中药复方或活性成分,为中医药有效治疗HFpEF提供参考,也为开发治疗HFpEF的新型药物提供方向。Heart failure(HF)is currently one of the diseases with most morbidity and mortality rates in the world.Among them,HF with preserved EF(HFpEF)accounts for a relatively high proportion of HF,and the current clinical treatment methods are still only to improve clinical symptoms,but cannot effectively treat the disease itself and reduce mortality due to HF.The prominent feature of HFpEF are diastolic dysfunction and ventricular muscle remodeling,and the remodeling of ventricular muscle is closely related to mitochondrial aberration.Therefore,this article reviews the key target proteins that lead to mitochondrial aberrations in HFpEF,such as mitochondrial biogenesis disorders,mitochondrial fission/fusion kinetic disorders,and mitochondrial autophagy abnormalities,and the mechanism and clinical research of traditional Chinese medicine with the effect of“replenishing qi and assisting yang”on HFpEF.To summarize and analyze the traditional Chinese medicine(TCM)compounds or active ingredients that can be used for the treatment of HFpEF,so as to provide a reference for the effective treatment of HFpEF by TCM,and also to provide a direction for the development of new HFpEF specific drugs.

关 键 词:射血分数保留型心力衰竭 线粒体畸变 中医药 

分 类 号:R541.61[医药卫生—心血管疾病]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象